IP Verse

Single Dose Anti-Pcv2 Pig Vaccine - EP2481420

The patent EP2481420 was granted to Boehringer Ingelheim Animal Health USA on Feb 20, 2019. The application was originally filed on Dec 14, 2007 under application number EP12155194A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2481420

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP12155194A
Filing Date
Dec 14, 2007
Status
Granted And Under Opposition
Jan 18, 2019
Grant Date
Feb 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATORIOS HIPRANov 20, 2019GRUNECKER PATENT -
CEVA SANTE ANIMALENov 19, 2019CABINET BECKER ET ASSOCIESADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2909462
DESCRIPTIONUS4708871
DESCRIPTIONUS6703023
DESCRIPTIONWO0072065
DESCRIPTIONWO0207721
DESCRIPTIONWO03049703
DESCRIPTIONWO2006007065
DESCRIPTIONWO2006072065
DESCRIPTIONWO2007028823
DESCRIPTIONWO9918214
EXAMINATIONWO2007028823
OPPOSITIONEP1926496
OPPOSITIONEP2481420
OPPOSITIONWO2006072065
OPPOSITIONWO2007028823
OPPOSITIONWO2008073464
OPPOSITIONWO2008076915
SEARCHWO03049703
SEARCHWO2005092069
SEARCHWO2006072065
SEARCHWO2007094893
SEARCHWO2008073464
SEARCHWO9929871

Non-Patent Literature (NPL) Citations (57) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALLAN; ELLIS, J VET. DIAGN. INVEST., (2000), vol. 12, pages 3 - 14
DESCRIPTION- ALLAN ET AL., VET. DIAGN. INVESTIGATION, (2000), vol. 12, pages 3 - 14
DESCRIPTION- ALTSCHUL, S. ET AL., BLAST Manual, NCVI NLM NIH BETHESDA
DESCRIPTION- ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
DESCRIPTION- BERGMANN ET AL., EUR. J. IMMUNOL., (1993), vol. 23, pages 2777 - 2781
DESCRIPTION- BERGMANN ET AL., J. IMMUNOL., (1996), vol. 157, pages 3242 - 3249
DESCRIPTION- CARILLO, H.; LIPMAN, D., SIAM J. APPLIED MATH., (1988), vol. 48, page 1073
DESCRIPTION- DEVEREUX, J., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
DESCRIPTION- Epitope Mapping Protocols in Methods in Molecular Biology, HUMANA PRESS, (1996), vol. 66
DESCRIPTION- GEYSEN ET AL., MOLEC. IMMUNOL., (1986), vol. 23, pages 709 - 715
DESCRIPTION- GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 3998 - 4002
DESCRIPTION- HARDING ET AL., SWINE HEALTH PROD, (1997), vol. 5, pages 201 - 203
DESCRIPTION- HIRAI ET AL., VET. RECORD, (2001), vol. 148, pages 482 - 484
DESCRIPTION- HUNTER ET AL., The Theory and Practical Application of Adjuvants, JOHNWILEY AND SONS, (1995), pages 51 - 94
DESCRIPTION- KENNEDY ET AL., J COMP PATHOL, (2000), vol. 122, pages 9 - 24
DESCRIPTION- LAROCHELLE ET AL., CAN. J. VET. RES., (2003), vol. 67, pages 114 - 120
DESCRIPTION- MAGAR ET AL., CAN. J. VET RES., (2000), vol. 64, pages 184 - 186
DESCRIPTION- MAGAR, J. COMP. PATHOL., (2000), vol. 123, pages 258 - 269
DESCRIPTION- MCKEOWN ET AL., CLIN. DIAGN. LAB. IMMUNOL., (2005), vol. 12, pages 1347 - 1351
DESCRIPTION- MUIRHEAD, VET. REC., (2002), vol. 150, page 456
DESCRIPTION- OPRIESSNIG ET AL., J. SWINE HEALTH PROD., (2004), vol. 12, pages 186 - 191
DESCRIPTION- PHAMEUROPA, (199606), vol. 8, no. 2
DESCRIPTION- RODRIGUEZ-ARRIOJA ET AL., AM. J VET. RES., (2002), vol. 63, pages 354 - 357
DESCRIPTION- SUHRBIER, A., IMMUNOL. AND CELL BIOL., (1997), vol. 75, pages 402 - 408
DESCRIPTION- SURADHAT; DAMRONGWATANAPOKIN, VET. MICROBIOL, (2003), vol. 92, pages 187 - 194
DESCRIPTION- TODD ET AL., VACCINE, (1997), vol. 15, pages 564 - 570
EXAMINATION- B Grosse Liesner, "Efficacy of Ingelvac CircoFLEX in face of maternal antibodies in a field trial in France", (20080101), URL: http://conservancy.umn.edu/handle/11299/153266, (20150929), XP055217028
EXAMINATION- "PCV-2-study", (20120101), URL: www.google.com, (20150929), XP055217048
EXAMINATION- Claire-Anne Siegrist ET AL, "Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice", European Journal of Immunology, (19981201), vol. 28, no. 12, doi:10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L, ISSN 0014-2980, pages 4138 - 4148, XP055217019
EXAMINATION- SIEGRIST C-A ED - GIERSING BIRGITTE K ET AL, "Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants", VACCINE, ELSEVIER LTD, GB, (20030728), vol. 21, no. 24, doi:10.1016/S0264-410X(03)00342-6, ISSN 0264-410X, pages 3406 - 3412, XP004436445
EXAMINATION- MCKEOWN N E ET AL, "Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20051101), vol. 12, no. 11, doi:10.1128/CDLI.12.11.1347-1351.2005, ISSN 1071-412X, pages 1347 - 1351, XP002557104
OPPOSITION- (20061023), URL: Ingelvac CircoFLEX TM Material Safety Data Sheet
OPPOSITION- A. Urniza, Et Al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Clinical and Diagnostic Laboratory Immunology, American Society for Microbiology, US, US, (20060101), vol. 2, ISSN 1556-6811, page 108, XP055446549
OPPOSITION- Fachinger, V. Bischoff, R. Jedidia, S.B. Saalmuller, A. Elbers, K., "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20080301), vol. 26, no. 11, ISSN 0264-410X, pages 1488 - 1499, XP022505432
OPPOSITION- HAAKE et al., Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies, (20130000), XP055502963
OPPOSITION- Ingelvac® CircoFLEX''' press release
OPPOSITION- Ingelvac® CircoFLEX''' Technical Bulletin
OPPOSITION- OPRIESSNIG et al., Derivation ofporcine circovirus type 2-negative pigs from positive breeding herd, (20040000), XP055165873
OPPOSITION- Peter Thomas, Et Al., "Effect of PCV2 passive antibody levels on immunization with chimeric PCVI-2 vaccine and challenge with wild-type PCV2", American Association Of Swine Veterinarians, (20050101), pages 23 - 26, XP055446519
OPPOSITION- Robert Desrosiers, Et Al., "Preliminary results with Ingelvac® CircoFLEX™ to protect multiple ages of Quebec pigs against PCVAD", American Association of swine Veterinarians, pages 143 - 146, American Association of swine Veterinarians, (20180131), XP055446462
OPPOSITION- USDA license to Ingelvac® CircoFLEX?
OPPOSITION- Weingartl, "Porcine circovirus structure and replication a minireview", Agricultura, vol. 1, pages 11 - 14, Agricultura, (20160802), XP055292683
OPPOSITION- C. CHAE et al., Postweaning multisystemic wasting syndrome a review of aetiology, diagnosis and pathology, (20040000), XP055277242
OPPOSITION- Siegrist, C.-A., "Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20030728), vol. 21, no. 24, doi:10.1016/S0264-410X(03)00342-6, ISSN 0264-410X, pages 3406 - 3412, XP004436445
OPPOSITION- MAGAR et al., Experimental transmission of porcine circovirus type 2 (PCV2) in Weaned Pigs: a Sequential Study, (20000000), XP055338746
OPPOSITION- MCKEOWN et al., Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2, (20050000), XP002557104
OPPOSITION- NAWAGITGUL et al., Modified Indirect Porcine Circovirus (PCV) Type 2- Based and Recombinant Capsid Protein (ORF2)-Based Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to PCV, (20020000), XP003004439
OPPOSITION- FENAUX et al., A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) cloned into the genomic backbone of the nanopathogenic PCVl induces protective immunity against PCV2 infection in pigs, (20040000), XP008039321
OPPOSITION- FENAUX M, ET AL., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", JOURNAL OF VIROLOGY., THE AMERICAN SOCIETY FOR MICROBIOLOGY., US, US, (20040601), vol. 78, no. 12, doi:10.1128/JVI.78.12.6297-6303.2004, ISSN 0022-538X, pages 6297 - 6303, XP008039321
SEARCH- ABBY R PATTERSON, "InterlaboratorycomparisonofPorcinecircovirus-2indirectimmunofluorescentantibodytestandenzyme-linkedimmunosorbentassayresultsonexperimentallyinfectedpigsAbbyR.Patterson,", JVETDIAGNINVEST, (20110101), vol. 23, pages 206 - 212, XP055031074 [T] 1-15 * the whole document *
SEARCH- BOEHRINGER INGELHEIM VETMEDICA ET AL, "IngelvacRCircoFLEXTM. Material safety date sheet", (20061023), INTERNET CITATION, URL: http://www.bimsds.us/msds/IngelvacCircoFlex_msds.pdf, (20070510), XP002433251 [A] 1-15 * the whole document *
SEARCH- ELISABETH BANHOLZER, "Eine Nachlese PCV2, PRRS, Mycoplasma hyopneumoniae, Improvac", IPVS CONGRESS 16-19 JULY 2006 COPENHAGEN, (20060701), XP055030916 [A] 1-15 * the whole document *
SEARCH- CHAE C, "A review of porcine circovirus 2-associated syndromes and diseases", VETERINARY JOURNAL, BAILLIERE TINDALL, LONDON, GB, (20050501), vol. 169, no. 3, ISSN 1090-0233, pages 326 - 336, XP004858799 [A] 1-15 * the whole document *
SEARCH- KAMSTRUP S ET AL, "Immunisation against PCV2 structural protein by DNA vaccination of mice", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20040329), vol. 22, no. 11-12, ISSN 0264-410X, pages 1358 - 1361, XP004500378 [A] 1-15
SEARCH- SEGALÉS JOAQUIM ET AL, "Pathological findings associated with naturally acquired porcine circovirus type 2 associated disease.", VETERINARY MICROBIOLOGY 4 FEB 2004, (20040204), vol. 98, no. 2, ISSN 0378-1135, pages 137 - 149, XP002557105 [A] 1-15 * the whole document *
SEARCH- OSTANELLO F ET AL, "Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus", VETERINARY MICROBIOLOGY, ELSEVIER BV, NL, (20050701), vol. 108, no. 3-4, ISSN 0378-1135, pages 179 - 186, XP004933318 [X] 1-8,14,15 * abstract * [Y] 1-15
SEARCH- MCKEOWN N E ET AL, "Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2.", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY NOV 2005, (200511), vol. 12, no. 11, ISSN 1071-412X, pages 1347 - 1351, XP002557104 [A] 1-15 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents